Alnylam Pharmaceuticals, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

647,839

Value ($000)

257,613

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	257,613	0.0%	647,839	12/31/2025
2025 Q3	11/10/2025	282,159	0.0%	618,770	9/30/2025
2025 Q2	8/12/2025	186,441	0.0%	571,747	6/30/2025
2025 Q1	9/15/2025	147,604	0.0%	546,642	3/31/2025
2024 Q4	2/6/2025	120,940	0.0%	513,962	12/31/2024
2024 Q3	11/12/2024	134,035	0.0%	487,348	9/30/2024
2024 Q2	8/12/2024	114,354	0.0%	470,592	6/30/2024
2024 Q1	5/9/2024	66,888	0.0%	447,560	3/31/2024
2023 Q4	2/6/2024	83,896	0.0%	438,304	12/31/2023
2023 Q3	11/8/2023	74,201	0.0%	418,980	9/30/2023
2023 Q2	8/10/2023	79,042	0.0%	416,144	6/30/2023
2023 Q1	5/12/2023	81,202	0.0%	405,363	3/31/2023
2022 Q4	2/13/2023	95,197	0.0%	400,576	12/31/2022
2022 Q3	11/14/2022	75,834	0.0%	378,865	9/30/2022
2022 Q2	8/15/2022	54,883	0.0%	376,297	6/30/2022
2022 Q1	5/13/2022	60,846	0.0%	372,623	3/31/2022
2021 Q4	2/11/2022	61,551	0.0%	362,961	12/31/2021
2021 Q3	11/16/2021	66,615	0.0%	352,815	9/30/2021
2021 Q2	8/16/2021	58,202	0.0%	343,331	6/30/2021
2021 Q1	5/17/2021	47,188	0.0%	334,213	3/31/2021
2020 Q4	2/16/2021	52,024	0.0%	400,276	12/31/2020
2020 Q3	11/13/2020	58,325	0.0%	400,579	9/30/2020
2020 Q2	8/20/2020	93,257	0.0%	629,644	6/30/2020
2020 Q1	5/15/2020	66,488	0.0%	610,819	3/31/2020
2019 Q4	2/7/2020	69,192	0.0%	600,778	12/31/2019
2014 Q2	7/30/2014	5,607	0.0%	88,748	6/30/2014
2014 Q1	4/29/2014	11,212	0.0%	166,989	3/31/2014
2013 Q4	2/14/2014	9,170	0.0%	142,535	12/31/2013